Complement activation following acute ischemic stroke

• Conditions: ischemic stroke; 10007963

• Registration Number: NL-OMON31843
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

a clinical diagnosis of ischemic stroke, the possibility to confirm the diagnosis with CT or MRI within 24 hours after inclusion in the study and admission within 24 hours of symptom onset.

Exclusion Criteria

Patients with symptoms of an infection, malignant or other underlying inflammatory disease and/or currently receiving anti-inflammatory or immunosuppressive medication will be excluded.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>see above</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>see above</p><br>